SCHEMBL4298982

SCHEMBL4298982

Clc1ccc2ccc3ccncc3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 2/20 0.49
MAPK10 P53779 3/20 0.44
HIPK2 Q9H2X6 1/20 0.44
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
KDM4E B2RXH2 2/20 0.43
HTT P42858 2/20 0.43
POLB P06746 1/20 0.43
RAD52 P43351 1/20 0.43
DYRK1A Q13627 3/20 0.42
CLK1 P49759 1/20 0.42
IMPDH2 P12268 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
CYP19A1 P11511 1/20 0.40
MAPK1 P28482 1/20 0.39
TNF P01375 1/20 0.39
NR4A2 P43354 1/20 0.38
NOS1 P29475 1/20 0.38
KCNH2 Q12809 1/20 0.38
AOC3 Q16853 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29569821 0.82 CLK1 (0.54) MAPK10HIPK2KDM4EHTTPOLB
SCHEMBL672509 0.82 CLK1 (0.54) MAPK10HIPK2KDM4EHTTPOLB
SCHEMBL25493421 0.79 AHR (0.49) CHUKPDGFRBPDGFRAKDM4EHTT
SCHEMBL29967989 0.79 CYP2A6 (0.52) DYRK1ANR4A2NOS1
SCHEMBL5411000 0.79 CYP2A6 (0.52) DYRK1ANR4A2NOS1
SCHEMBL691988 0.78 PRKCZ (0.50) CHUKPDGFRBPDGFRADYRK1ACLK1
SCHEMBL30012364 0.78 CYP2A6 (0.50) CHUKPDGFRBPDGFRADYRK1AIMPDH2
SCHEMBL1538404 0.78 CYP2A6 (0.50) CHUKPDGFRBPDGFRADYRK1AIMPDH2
SCHEMBL25571239 0.78 ROCK1 (0.44) CHUKMAPK10HIPK2PDGFRBPDGFRA
SCHEMBL24958270 0.77 AHR (0.53) CHUKHIPK2KDM4EHTTDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
WO-2007008502-A2 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258852-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, CDKN1A CHUK 152/4885MAPK10 1069/4885HIPK2 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.